Type
Internal restructuring
Country
France
Region
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

373 jobs
Number of planned job losses
Job loss
95 jobs
Number of planned job creations
Job creation
Announcement Date
20 September 2011
Employment effect (start)
1 December 2011
Foreseen end date

Description

On 20 September, French subsidiary of US pharma Pfizer (1,453 employees) announced to cut 373 positions, mainly pharmaceutical sales representatives who supply both general practitioners and the specialized doctors working in hospitals. 

At the same time, the company intends to create 95 jobs. Unions estimate a workforce reduction of around 748 (half of the total workforce): 373 job cuts and 375 changes in working conditions that could be refused by the affected employees (in case of refusals they could face dismissal).

In 2009, Pfizer had already cut 700 jobs. The company fears the consequences of the loss of patent on its blockbuster Lipitor. The company also decided to cut 40% of its workforce in Belgium, 50% in Germany and in Iceland, and more than 50% in Italy.


Sources

  • 20 September 2011: Libération
  • 21 September 2011: Les Echos
  • 20 September 2011: AFP Liaisons sociales

Citation

Eurofound (2011), Pfizer, Internal restructuring in France, factsheet number 72386, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/72386.